Hormone Receptor Positive Metastatic Breast Cancer

DBCOND0120563Epidermal and dermal conditions Female Urogenital and Breast Diseases

Hormone Receptor Positive Metastatic Breast Cancer is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: metastatic hormone receptor positive Breast cancer · Hormone Receptor-positive Metastatic Breast Cancer
Classified under: Epidermal and dermal conditions
Female Urogenital and Breast Diseases
Neoplasms
Indicated drugs: Sacituzumab govitecan
Trastuzumab

What you can answer from here — as of November 01, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

4Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Hormone Receptor Positive Metastatic Breast Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account